Organism name | Ferula szowitsiana |
---|---|
Genus | Ferula |
Family | Apiaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Ferula szowitsiana |
---|---|
Linked NCBI taxonomy ID | 555415 |
Linked level | species |
Family in NCBI taxonomy | Apiaceae |
---|---|
ID | 4037 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00003672 |
Sitosterol
/ beta-sitosterl / (-)-beta-Sitosterol / Stigmast-5-en-3beta-ol |
CHEMBL221542
CHEMBL1398443 CHEMBL1875388 |
17 / 19 / 12 | No. 53 | No. 11 | |||
C00003674 |
Stigmasterol
/ beta-Stigmasterol |
CHEMBL66943
CHEMBL186373 CHEMBL400247 CHEMBL1568947 |
D013265
|
5 / 0 / 0 | 1 / 0 | No. 53 | No. 11 | |
C00034703 |
Szowitsiacoumarin A
/ (+)-Szowitsiacoumarin A |
No. 209 | ||||||
C00034704 |
Szowitsiacoumarin B
/ (+)-Szowitsiacoumarin B |
CHEMBL270298
|
No. 209 | |||||
C00029763 |
Auraptene
|
CHEMBL307341
|
C105832
|
28 / 25 / 26 | 3 / 0 | No. 335 | ||
C00034380 |
2-Epihelmanticine
|
No. 1913 | ||||||
C00034507 |
Farnesiferol B
|
CHEMBL272886
CHEMBL1082630 CHEMBL1083019 |
No. 1958 | |||||
C00034508 |
Farnesiferol C
|
CHEMBL177697
CHEMBL270486 |
No. 2027 | |||||
C00034520 |
Galbanic acid
|
CHEMBL1078509
|
C048972
|
No. 2027 | ||||
C00034737 |
Umbelliprenin
|
CHEMBL156127
|
8 / 3 / 3 | No. 2038 | ||||
C00034601 |
Methyl galbanate
|
No. 2552 | ||||||
C00034625 |
Persicasulfide A
/ (-)-Persicasulfide A |
No. 8909 |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00003672 C00029763 C00034737 | 1 / 1 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00029763 C00034737 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00029763 C00034737 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00003672 C00029763 | 0 / 1 |
P06746 | DNA polymerase beta | Enzyme | C00003672 C00003674 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00029763 C00034737 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00029763 C00034737 | 0 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00029763 C00034737 | 2 / 2 |
P14679 | Tyrosinase | Oxidoreductase | C00003672 | 4 / 2 |
P34969 | 5-hydroxytryptamine receptor 7 | Serotonin receptor | C00003674 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00003672 | 1 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00003672 | 0 / 1 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00029763 | 0 / 0 |
P08047 | Transcription factor Sp1 | Unclassified protein | C00003672 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00034737 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00029763 | 2 / 0 |
Q13315 | Serine-protein kinase ATM | Atypical serine/threonine protein kinase PIKK subfamily | C00029763 | 1 / 4 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00003672 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00029763 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00029763 | 1 / 1 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00029763 | 0 / 0 |
P04062 | Glucosylceramidase | Enzyme | C00029763 | 6 / 4 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00029763 | 0 / 0 |
P00734 | Prothrombin | S1A | C00003672 | 4 / 2 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00003672 | 3 / 2 |
P06280 | Alpha-galactosidase A | Enzyme | C00029763 | 1 / 1 |
Q96RI1 | Bile acid receptor | NR1H4 | C00029763 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00029763 | 0 / 0 |
P56817 | Beta-secretase 1 | A1A | C00029763 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00003672 | 0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00029763 | 3 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00029763 | 2 / 2 |
P03372 | Estrogen receptor | NR3A1 | C00003672 | 1 / 1 |
P09884 | DNA polymerase alpha catalytic subunit | Transferase | C00003674 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00003672 | 1 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00003672 | 1 / 1 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00003672 | 2 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00034737 | 0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00029763 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00029763 | 4 / 3 |
P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00003672 | 1 / 1 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00029763 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00029763 | 0 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00003672 | 0 / 0 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00029763 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00029763 | 1 / 4 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00003674 | 0 / 0 |
Q02880 | DNA topoisomerase 2-beta | Isomerase | C00003674 | 0 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00029763 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00029763
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00029763
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00029763
|
10599 | SLCO1B1, HBLRR, LST-1, LST1, OATP-C, OATP1B1, OATP2, OATPC, SLC21A6 | solute carrier organic anion transporter family, member 1B1 |
C00003674
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#218030 | Apparent mineralocorticoid excess; ame |
P80365
|
#208900 | Ataxia-telangiectasia; at |
Q13315
|
#114500 | Colorectal cancer; crc |
P84022
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#615363 | Estrogen resistance; estrr |
P03372
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
#613679 | Prothrombin deficiency, congenital |
P00734
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#601367 | Stroke, ischemic |
P00734
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | name | UniProt |
---|---|---|
H00223 | Inherited thrombophilia |
P00734
(related)
|
H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
|
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00038 | Malignant melanoma |
P14679
(marker)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00259 | Apparent mineralocorticoid excess syndrome |
P80365
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
Q13315
(related)
|
H00064 | Ataxia telangiectasia (AT) |
Q13315
(related)
|
H00094 | DNA repair defects |
Q13315
(related)
|
H00848 | Ataxia with ocular apraxia (AOA) |
Q13315
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|